# Initial experience with teriparatide in the United States.

> PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-16684431-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16684431-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16684431-teriparatide-v1.json
- Content SHA-256: `c3cfbba4d934992ae2ac4f1bc4c8971a4cf11ec6edfc9e0946938b717d685e6f`

## Claims and source pins

### Headline

Initial experience with teriparatide in the United States. ([`pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4`](#source-pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4))

### Summary

PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4`](#source-pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4))

### Paragraph 1

PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4`](#source-pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4`](#source-pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4))

## Sources

<a id="source-pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4"></a>
- **Initial experience with teriparatide in the United States. · retained source version 1:2013-11-21:current:85823488c3d427ea1f8fdda0e0e95ef35ff92f34f825bf7af62e27eba0e2bb22** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16684431/) (`pubmed-observation-pmid-16684431-2013-11-21-85823488c3d4`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Initial experience with teriparatide in the United States." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16684431-teriparatide-v1.json SHA-256: c3cfbba4d934992ae2ac4f1bc4c8971a4cf11ec6edfc9e0946938b717d685e6f.